South Korea's Yuhan Chemical Expands APIs CDMO Business

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Yuhan Corporation (Seoul) is expanding its active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) business through its subsidiary Yuhan Chemical.

After building a new production building (HB building) at its Hwaseong plant in November last year, Yuhan Chemical has been working on the 19.7 billion-won (US$14.7 million) BAY-2 construction in the HB building since the end of last year.

With the goal of completion in December, it is expected to begin full-scale commercial production in March of next year after going through procedures such as commissioning.

Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical-Biotech Industry Project Database can click here to read the detailed project report.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 Trillion (USD).